ARTICLE | Company News
Ascend, Valeant sales and marketing update
October 8, 2007 7:00 AM UTC
VRX granted Ascend exclusive rights to market Migranal dihydroergotamine nasal spray to OB/GYNs in the U.S. to treat migraine headaches. VRX will continue to market the drug to physicians outside the...